Cargando…
Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry
IMPORTANCE: Multiple sclerosis can also affect children. Approximately 3–10% of patients develop multiple sclerosis before the age of 16. OBJECTIVE: The aim of this analysis is to describe the characteristics of pediatric patients with multiple sclerosis who started their treatment with disease-modi...
Autores principales: | Vališ, Martin, Pavelek, Zbyšek, Novotný, Michal, Klímová, Blanka, Šarláková, Jana, Halúsková, Simona, Peterka, Marek, Štětkárová, Ivana, Štourač, Pavel, Mareš, Jan, Hradílek, Pavel, Ampapa, Radek, Vachová, Marta, Recmanová, Eva, Meluzínová, Eva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062179/ https://www.ncbi.nlm.nih.gov/pubmed/35518208 http://dx.doi.org/10.3389/fneur.2022.851426 |
Ejemplares similares
-
Comparison of Therapies in MS Patients After the First Demyelinating Event in Real Clinical Practice in the Czech Republic: Data From the National Registry ReMuS
por: Pavelek, Zbyšek, et al.
Publicado: (2021) -
Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase
por: Pavelek, Zbyšek, et al.
Publicado: (2020) -
Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy
por: Vališ, Martin, et al.
Publicado: (2020) -
The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis
por: Vališ, Martin, et al.
Publicado: (2023) -
Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis
por: Peterka, Marek, et al.
Publicado: (2023)